BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3277660)

  • 1. Epithelial distribution of a myelomonocytic antigen LI in relation to cutaneous malignancies and melanocytic naevi.
    Gabrielsen TO; Brandtzaeg P; Hoel PS; Dale I
    Br J Dermatol; 1988 Jan; 118(1):59-67. PubMed ID: 3277660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index.
    Tokuda Y; Mukai K; Matsuno Y; Furuya S; Shimosato Y; Takasaki Y; Saida T; Ishihara K
    Arch Dermatol Res; 1992; 284(6):319-23. PubMed ID: 1363460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions.
    Mackie RM; Campbell I; Turbitt ML
    J Clin Pathol; 1984 Apr; 37(4):367-72. PubMed ID: 6200506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the antigen recognized by mAb GB36 in normal skin and in skin tumours.
    Hofman P; Lacour JP; Emiliozzi C; Staquet MJ; Hsi BL; Rossi B; Ortonne JP
    Br J Dermatol; 1995 Dec; 133(6):874-83. PubMed ID: 8547038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
    Takahashi H; Strutton GM; Parsons PG
    Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moesin and CD44 expression in cutaneous melanocytic tumours.
    Ichikawa T; Masumoto J; Kaneko M; Saida T; Sagara J; Taniguchi S
    Br J Dermatol; 1998 May; 138(5):763-8. PubMed ID: 9666819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases.
    Gabrielsen TO; Dale I; Brandtzaeg P; Hoel PS; Fagerhol MK; Larsen TE; Thune PO
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):173-9. PubMed ID: 2427557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
    White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
    J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial membrane antigen staining of melanocytic nevi.
    Cramer SF
    Hum Pathol; 1990 Jan; 21(1):121-2. PubMed ID: 2295503
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistological detection of human malignant melanoma using monoclonal antibody to a melanoma-associated antigen.
    Kageshita T; Johno M; Ono T; Arao T; Imai K
    Arch Dermatol Res; 1985; 277(4):334-6. PubMed ID: 3890772
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cross-reacting antigen common to stratified squamous epithelium and Streptococcus group A in tumors of epidermal origin].
    Silagadze DG; Beletskaia LV; Berenbein VA; Kolesnikova VIu
    Vopr Onkol; 1981; 27(6):27-32. PubMed ID: 7023039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth dynamics of acquired melanocytic nevi. Higher reactivity of proliferating cell nuclear antigen in junctional and compound nevi than intradermal nevi.
    Tokuda Y; Saida T; Mukai K; Takasaki Y
    J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):220-4. PubMed ID: 7913717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma.
    Bäckvall H; Wolf O; Hermelin H; Weitzberg E; Pontén F
    Br J Dermatol; 2004 Feb; 150(2):259-66. PubMed ID: 14996096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of MAC 387 antibody as a diagnostically useful marker of L1 epithelial antigen expression by lung tumours.
    Mayall FG; Gibbs AR
    J Pathol; 1991 May; 164(1):47-50. PubMed ID: 1647450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related proliferative activity in dermal melanocytic naevi detected by PCNA/cyclin expression.
    Tu P; Miyauchi S; Miki Y
    Br J Dermatol; 1993 Jul; 129(1):65-8. PubMed ID: 8103667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in skin and related tumours as determined by immunohistological techniques.
    Scurry J; de Boer WG
    Pathology; 1983 Oct; 15(4):379-84. PubMed ID: 6371679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to basal epidermal cells in patients with basal or squamous cell carcinoma.
    Ackermann-Schopf CM
    Arch Dermatol Res (1975); 1976 Dec; 257(2):149-56. PubMed ID: 1008612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma antigen-encoding gene expression in melanocytic naevi and cutaneous malignant melanomas.
    Basarab T; Picard JK; Simpson E; Russell-Jones R
    Br J Dermatol; 1999 Jan; 140(1):106-8. PubMed ID: 10215777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.